2352 related articles for article (PubMed ID: 25838376)
21. [Cytotoxic T lymphocytes: role in immunosurveillance and in immunotherapy].
Benchetrit F; Gazagne A; Adotevi O; Haicheur N; Godard B; Badoual C; Fridman WH; Tartour E
Bull Cancer; 2003; 90(8-9):677-85. PubMed ID: 14609756
[TBL] [Abstract][Full Text] [Related]
22. Effect of tumor cells and tumor microenvironment on NK-cell function.
Vitale M; Cantoni C; Pietra G; Mingari MC; Moretta L
Eur J Immunol; 2014 Jun; 44(6):1582-92. PubMed ID: 24777896
[TBL] [Abstract][Full Text] [Related]
23. Virus-specific memory T cells populate tumors and can be repurposed for tumor immunotherapy.
Rosato PC; Wijeyesinghe S; Stolley JM; Nelson CE; Davis RL; Manlove LS; Pennell CA; Blazar BR; Chen CC; Geller MA; Vezys V; Masopust D
Nat Commun; 2019 Feb; 10(1):567. PubMed ID: 30718505
[TBL] [Abstract][Full Text] [Related]
24. Plasticity beyond cancer cells and the "immunosuppressive switch".
Granot Z; Fridlender ZG
Cancer Res; 2015 Nov; 75(21):4441-5. PubMed ID: 26475869
[TBL] [Abstract][Full Text] [Related]
25. Tumor resistance to CD8+ T cell-based therapeutic vaccination.
Huang Y; Shah S; Qiao L
Arch Immunol Ther Exp (Warsz); 2007; 55(4):205-17. PubMed ID: 17659376
[TBL] [Abstract][Full Text] [Related]
26. Targeting the tumor microenvironment by immunotherapy: part 2.
Leibovici J; Itzhaki O; Huszar M; Sinai J
Immunotherapy; 2011 Nov; 3(11):1385-408. PubMed ID: 22053888
[TBL] [Abstract][Full Text] [Related]
27. The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor Microenvironment.
Gajewski TF
Semin Oncol; 2015 Aug; 42(4):663-71. PubMed ID: 26320069
[TBL] [Abstract][Full Text] [Related]
28. Immune checkpoint blockade immunotherapy to activate anti-tumour T-cell immunity.
Ramsay AG
Br J Haematol; 2013 Aug; 162(3):313-25. PubMed ID: 23691926
[TBL] [Abstract][Full Text] [Related]
29. Oncology meets immunology: the cancer-immunity cycle.
Chen DS; Mellman I
Immunity; 2013 Jul; 39(1):1-10. PubMed ID: 23890059
[TBL] [Abstract][Full Text] [Related]
30. DNA vaccine against tumor endothelial marker 8 inhibits tumor angiogenesis and growth.
Ruan Z; Yang Z; Wang Y; Wang H; Chen Y; Shang X; Yang C; Guo S; Han J; Liang H; Wu Y
J Immunother; 2009 Jun; 32(5):486-91. PubMed ID: 19609240
[TBL] [Abstract][Full Text] [Related]
31. [Tumor rejection antigen and cancer immunotherapy].
Matsutake T; Nakayama E
Gan To Kagaku Ryoho; 1995 Nov; 22(13):1871-7. PubMed ID: 7487115
[TBL] [Abstract][Full Text] [Related]
32. Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment.
Gajewski TF; Woo SR; Zha Y; Spaapen R; Zheng Y; Corrales L; Spranger S
Curr Opin Immunol; 2013 Apr; 25(2):268-76. PubMed ID: 23579075
[TBL] [Abstract][Full Text] [Related]
33. Vascular regulation of antitumor immunity.
Munn LL; Jain RK
Science; 2019 Aug; 365(6453):544-545. PubMed ID: 31395771
[TBL] [Abstract][Full Text] [Related]
34. A study of dendritic and endothelial cell interactions in colon cancer in a cell line and small mammal model.
Yoneyama S; Okaji Y; Tsuno NH; Kawai K; Yamashita H; Tsuchiya T; Yamada J; Sunami E; Osada T; Kitayama J; Takahashi K; Nagawa H
Eur J Surg Oncol; 2007 Dec; 33(10):1191-8. PubMed ID: 17314028
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxic T lymphocyte migration and effector function in the tumor microenvironment.
Weigelin B; Krause M; Friedl P
Immunol Lett; 2011 Jul; 138(1):19-21. PubMed ID: 21333682
[TBL] [Abstract][Full Text] [Related]
36. Immune surveillance and immunotherapy: lessons from carbohydrate mimotopes.
Pashov A; Monzavi-Karbassi B; Kieber-Emmons T
Vaccine; 2009 May; 27(25-26):3405-15. PubMed ID: 19200843
[TBL] [Abstract][Full Text] [Related]
37. Immune microenvironment profiles of tumor immune equilibrium and immune escape states of mouse sarcoma.
Wu X; Peng M; Huang B; Zhang H; Wang H; Huang B; Xue Z; Zhang L; Da Y; Yang D; Yao Z; Zhang R
Cancer Lett; 2013 Oct; 340(1):124-33. PubMed ID: 23920127
[TBL] [Abstract][Full Text] [Related]
38. Immunosuppressive mechanisms in human tumors: why we still cannot cure cancer.
Gross S; Walden P
Immunol Lett; 2008 Feb; 116(1):7-14. PubMed ID: 18164076
[TBL] [Abstract][Full Text] [Related]
39. Boosting immune system against cancer by melatonin: A mechanistic viewpoint.
Mortezaee K; Potes Y; Mirtavoos-Mahyari H; Motevaseli E; Shabeeb D; Musa AE; Najafi M; Farhood B
Life Sci; 2019 Dec; 238():116960. PubMed ID: 31629760
[TBL] [Abstract][Full Text] [Related]
40. T cells and cancer - why do the killers become exhausted?
Brück O; Keränen M; Dufva O; Kreutzman A; Mustjoki S
Duodecim; 2016; 132(21):1984-92. PubMed ID: 29190050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
